1st of its kind The FDA just approved the first ever GLP-1 pill for weight loss, according to a Novo Nordisk, the makers of Wegovy, news release
We enrolled 46 (of 81 screened) 35-year-old preschool children with confirmed ASD
Psychiatry 97 , 2840 (2025)
Glucagon-Like Peptide-1 Receptor Agonists Improve Biomarkers Of Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis Of Randomised Controlled Trials
If fatigue is severe enough to affect your ability to carry out daily activities, persists beyond eight weeks at a stable dose, or is accompanied by dizziness, breathlessness, confusion or significant weakness, contact your SheMed clinician
Sustainability: Can I afford and maintain this plan long enough for it to make sense